Document is current
Any future updates will be listed below
-
Authors
Lima, Thais Pinheiro
Assuncao, Antonildes N.
Bittencourt, Marcio Sommer
Liberato, Gabriela
Arbab-Zadeh, Armin
Lima, Joao A. C.
Rochitte, Carlos Eduardo https://orcid.org/0000-0003-4505-3344
- License Information
-
More Information
Article History
Received: 11 February 2022
Revised: 13 December 2022
Accepted: 27 December 2022
First Online: 18 February 2023
Declarations
:
: The scientific guarantor of this publication is Carlos E. Rochitte.Dr. Rochitte accepts official responsibility for the overall integrity of the manuscript (including ethics, data handling, reporting of results, and study conduct).
: Thaís Pinheiro Lima receveid speaker fees of Pfizer. Marcio Sommer Bittencourt received a research grant from Sanofi; speaker fees of Novartis, Novo Nordisk, EMS, and GE Healthcare; and consulting fee from Bayer. Armin Arbab-Zadeh received grant support from Canon. Joao AC Lima received grant support from Canon. Carlos E. Rochitte receveid speaker fees from Pfizer. The others authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise and we thank our stats team for their support.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was not required in this study because this is a sub-study of two larger multicenter studies (CORE64 and CORE320) that received ethical approval.
: Some study subjects or cohorts have been previously reported in CORE64 and CORE320 studies.
: • retrospective.• diagnostic or prognostic study.• performed at one institution.
